Bristol Myers Squibb BMY
NYSE BMY
$61.74 +0.62 (+1.01%)
As of: Oct 22, 2026 · 10:00 AM EDT

Bristol Myers Squibb (BMY) Curent Deferred Tax Liability (2009 - 2012)

Updated

Analysis

Bristol Myers Squibb (BMY) Curent Deferred Tax Liability (2009 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn -
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn -
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn -
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn -
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -
10 Bristol Myers Squibb 125.88 Bn 77.15 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -10.00 Mn
Dec 31, 2011 -6.00 Mn
Dec 31, 2010 -5.00 Mn
Dec 31, 2009 8.00 Mn
API Access

Bristol Myers Squibb Curent Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=BMY&period=max&api_key=YOUR_API_KEY